http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107349194-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-73 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-255 |
| filingDate | 2017-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107349194-B |
| titleOfInvention | Application of sulfonate compound in preparation of anti-cervical cancer drug |
| abstract | The invention provides an application of (1R,5S) - (6, 6-dimethylbicyclo [3,1,1] hept-2-ene-2-yl) sulfonate compounds in preparation of anti-cervical cancer drugs, wherein the (1R,5S) - (6, 6-dimethylbicyclo [3,1,1] hept-2-ene-2-yl) sulfonate compounds are one of the following chemical formulas: (1R,5S) - (6, 6-dimethylbicyclo [3,1,1] hept-2-en-2-yl) benzenesulfonate, (1R,5S) - (6, 6-dimethylbicyclo [3,1,1] hept-2-en-2-yl) p-toluenesulfonate. The effect of the compound is verified by combining cell cycle detection, apoptosis detection and cervical cancer cell line activity inhibition, and the result shows that the compound has a remarkable cervical cancer cell activity inhibition effect, is low in toxicity, efficient and stable, enriches an anticancer compound library, and provides powerful technical support for preparing anticancer drugs or pharmaceutical compositions. |
| priorityDate | 2017-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.